238 related articles for article (PubMed ID: 36168256)
1. Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity.
Mahoudeau A; Anquetil C; Tawara N; Khademian H; Amelin D; Bolko L; Silvestro M; Cin JD; Tendrel B; Tardif V; Mariampillai K; Butler-Browne G; Benveniste O; Allenbach Y
Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12849. PubMed ID: 36168256
[TBL] [Abstract][Full Text] [Related]
2. Classification of idiopathic inflammatory myopathies: pathology perspectives.
Tanboon J; Nishino I
Curr Opin Neurol; 2019 Oct; 32(5):704-714. PubMed ID: 31369423
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiological Mechanisms and Treatment of Dermatomyositis and Immune Mediated Necrotizing Myopathies: A Focused Review.
Kamperman RG; van der Kooi AJ; de Visser M; Aronica E; Raaphorst J
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457124
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
[TBL] [Abstract][Full Text] [Related]
5. SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies.
Graf M; von Stuckrad SL; Uruha A; Klotsche J; Zorn-Pauly L; Unterwalder N; Buttgereit T; Krusche M; Meisel C; Burmester GR; Hiepe F; Biesen R; Kallinich T; Stenzel W; Schneider U; Rose T
RMD Open; 2022 Feb; 8(1):. PubMed ID: 35177553
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic myopathies.
Mammen AL
Handb Clin Neurol; 2024; 200():327-332. PubMed ID: 38494286
[TBL] [Abstract][Full Text] [Related]
7. Alterations in activin A-myostatin-follistatin system associate with disease activity in inflammatory myopathies.
Vernerová L; Horváthová V; Kropáčková T; Vokurková M; Klein M; Tomčík M; Oreská S; Špiritović M; Štorkánová H; Heřmánková B; Kubínová K; Kryštůfková O; Mann H; Ukropec J; Ukropcová B; Vencovský J
Rheumatology (Oxford); 2020 Sep; 59(9):2491-2501. PubMed ID: 31990347
[TBL] [Abstract][Full Text] [Related]
8. Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum.
Zierer LK; Naegel S; Schneider I; Kendzierski T; Kleeberg K; Koelsch AK; Scholle L; Schaefer C; Naegel A; Zierz S; Otto M; Stoltenburg-Didinger G; Kraya T; Stoevesandt D; Mensch A
J Neurol; 2024 Jun; 271(6):3186-3202. PubMed ID: 38438820
[TBL] [Abstract][Full Text] [Related]
9. Dipeptidyl peptidase 4/CD26 expression in human idiopathic inflammatory myopathies reveals skeletal muscle injury and vascular inflammation.
De Lorenzo R; Monno A; Sciorati C; Lorenzetti I; Cavalli S; Bonomi F; Previtali SC; Rovere-Querini P
Clin Exp Rheumatol; 2022 Feb; 40(2):237-246. PubMed ID: 34796850
[TBL] [Abstract][Full Text] [Related]
10. Evaluating disease status in idiopathic inflammatory myopathies with quantitative muscle ultrasound.
Tan JY; Tan CY; Yahya MA; Shahrizaila N; Goh KJ
Muscle Nerve; 2024 May; 69(5):597-603. PubMed ID: 38488306
[TBL] [Abstract][Full Text] [Related]
11. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-35 in idiopathic inflammatory myopathies.
Mann H; Kryštůfková O; Zámečník J; Háček J; Hulejová H; Filková M; Vencovský J; Šenolt L
Cytokine; 2021 Jan; 137():155350. PubMed ID: 33128920
[TBL] [Abstract][Full Text] [Related]
13. Local expression of cytokines in idiopathic inflammatory myopathies.
Lepidi H; Frances V; Figarella-Branger D; Bartoli C; Machado-Baeta A; Pellissier JF
Neuropathol Appl Neurobiol; 1998 Feb; 24(1):73-9. PubMed ID: 9549732
[TBL] [Abstract][Full Text] [Related]
14. [Idiopathic inflammatory myopathies. A review].
Acosta I; Matamala JM; Jara P; Pino F; Gallardo A; Verdugo R
Rev Med Chil; 2019 Mar; 147(3):342-355. PubMed ID: 31344172
[TBL] [Abstract][Full Text] [Related]
15. The role of interferons type I, II and III in myositis: A review.
Bolko L; Jiang W; Tawara N; Landon-Cardinal O; Anquetil C; Benveniste O; Allenbach Y
Brain Pathol; 2021 May; 31(3):e12955. PubMed ID: 34043262
[TBL] [Abstract][Full Text] [Related]
16. Where are we moving in the classification of idiopathic inflammatory myopathies?
Tanboon J; Uruha A; Stenzel W; Nishino I
Curr Opin Neurol; 2020 Oct; 33(5):590-603. PubMed ID: 32852298
[TBL] [Abstract][Full Text] [Related]
17. Possible future avenues for myositis therapeutics: DM, IMNM and IBM.
Connolly CM; Plomp L; Paik JJ; Allenbach Y
Best Pract Res Clin Rheumatol; 2022 Jun; 36(2):101762. PubMed ID: 35778272
[TBL] [Abstract][Full Text] [Related]
18. Radiographic patterns of muscle involvement in the idiopathic inflammatory myopathies.
Day JA; Bajic N; Gentili S; Patel S; Limaye V
Muscle Nerve; 2019 Nov; 60(5):549-557. PubMed ID: 31397909
[TBL] [Abstract][Full Text] [Related]
19. Identification of Unique microRNA Profiles in Different Types of Idiopathic Inflammatory Myopathy.
Muñoz-Braceras S; Pinal-Fernandez I; Casal-Dominguez M; Pak K; Milisenda JC; Lu S; Gadina M; Naz F; Gutierrez-Cruz G; Dell'Orso S; Torres-Ruiz J; Grau-Junyent JM; Selva-O'Callaghan A; Paik JJ; Albayda J; Christopher-Stine L; Lloyd TE; Corse AM; Mammen AL
Cells; 2023 Sep; 12(17):. PubMed ID: 37681930
[TBL] [Abstract][Full Text] [Related]
20. Acquired immune and inflammatory myopathies: pathologic classification.
Pestronk A
Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
